Tyler Jacks

Prof. Jacks is Director of the Koch Institute for Integrative Cancer Research at MIT – a National Cancer Institute (NCI)-designated Cancer Center, where he also directs a major research laboratory carrying out cutting-edge studies in cancer genetics and cancer immunology.​ Prof. Jacks has pioneered the use of gene targeting technology to study cancer-associated genes and to construct mouse models of many human cancer types, closely recapitulating human disease and yielding novel insights into tumor development as well as new strategies for cancer detection and treatment. Prof Jacks has served as Chair of the National Cancer Advisory Board of the NCI, was a member of the Board of Directors of the American Association for Cancer Research (AACR), and is a past President of the AACR. He was elected to the National Academy of Sciences, the Institute of Medicine of the National Academies, the American Academy of Arts and Sciences and the inaugural class of Fellows of the AACR Academy. Prof Jacks was co-chair of the White House's Cancer "Moonshot" Blue Ribbon Panel.​ He has a bachelor’s degree in Biology from Harvard, and a Ph.D. from UC San Francisco, where he trained with Nobel Laureate Harold Varmus.